Antoanella Bardan and Tissa Hata

Department of Medicine, Division of Dermatology, University of California, San Diego, California, U.S.A.

■ Introduction 545

■ Cowden's Syndrome 545

■ Definition 545

■ Epidemiology 545

■ Pathogenesis 545

■ Clinical Manifestations 545

■ Diagnosis 546

■ Treatment 547

■ Complications and Prognosis

548

■ Summary 548

■ Muir-Torre Syndrome 548

■ Definition 548

■ Epidemiology 548

■ Pathogenesis 548

■ Clinical Manifestations 548

■ Diagnosis 549

■ Treatment 550

■ Complications and Prognosis

550

■ Summary 551

■ Peutz-Jeghers Syndrome 551

■ Definition 551

■ Epidemiology 551

■ Pathogenesis 551

■ Clinical Manifestations 551

■ Diagnosis 552

■ Treatment 552

■ Complications and Prognosis

553

■ Summary 553

■ Hereditary Hemorrhagic Telangiectasia 553

■ Definition 553

■ Epidemiology 553

■ Clinical Manifestations 554

■ Diagnosis and Treatment 554

■ Complications and Prognosis 555

■ Stevens-Johnson Syndrome 555

■ Definition 555

■ Epidemiology 556

■ Pathogenesis 556

■ Clinical Manifestations 556

■ Diagnosis 557

■ Treatment 557

■ Complications and Prognosis 557

■ Hansen's Disease 558

■ Definition 558

■ Epidemiology 558

■ Pathogenesis 558

■ Clinical Manifestations 558

■ Diagnosis 560

■ Treatment 560

■ Complications and Prognosis 560

■ Glucagonoma Syndrome 561

■ Definition 561

■ Epidemiology 561

■ Pathogenesis 561

■ Clinical Manifestations 561

■ Diagnosis 562

■ Treatment 562

■ Complications and Prognosis 562

■ References 563

0 0

Post a comment